Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ALLR
ALLR logo

ALLR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Allarity Therapeutics Inc (ALLR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.430
1 Day change
6.72%
52 Week Range
2.350
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Allarity Therapeutics Inc (ALLR) does not present a strong buy opportunity for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The lack of significant trading trends, no recent news, neutral technical indicators, and absence of positive catalysts suggest that holding off on this stock is the best course of action currently.

Technical Analysis

The MACD histogram is negative and contracting (-0.0374), the RSI is neutral at 42.455, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 1.497, with key resistance at 1.663 and support at 1.33.

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress.

Neutral/Negative Catalysts

  • The stock has a 50% chance of declining by -3.92% in the next week and -0.82% in the next month based on similar candlestick patterns. Technical indicators are neutral to slightly bearish.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes.

Wall Street analysts forecast ALLR stock price to rise
1 Analyst Rating
Wall Street analysts forecast ALLR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.340
sliders
Low
9.5
Averages
9.5
High
9.5
Current: 1.340
sliders
Low
9.5
Averages
9.5
High
9.5
Ascendiant
NULL -> Buy
initiated
$9
AI Analysis
2025-07-28
Reason
Ascendiant
Price Target
$9
AI Analysis
2025-07-28
initiated
NULL -> Buy
Reason
Ascendiant initiated coverage of Allarity with a Buy rating and $9 price target. The firm sees large market opportunities for the company's DRP platform and Stenoparib drug. It believes positive clinical trial data in 2025 and 2026 will be catalysts for the shares.

People Also Watch